You are here
IMDRF consultation: Proposed update to document on Post-Market Clinical Follow-Up Studies
This consultation closed on Friday, 11 December 2020.
The International Medical Device Regulators Forum (IMDRF) working group on Medical Device Clinical Evaluation (MDCE) has updated a previous document from the Global Harmonisation Task Force (GHTF) on Post Market Clinical Follow-up (PMCF) Studies. This is designed to promote global harmonisation around understanding and use of PMCF studies. The working group chair is Dr Yinghui Liu (China).
This draft IMDRF document is part of a series on Clinical Evaluation and aims to strengthen the role of PMCF studies in meeting evidence requirements regarding the Essential Principles and improving risk management throughout the lifecycle of medical devices. It provides guidance regarding: circumstances where a PMCF study is indicated; general principles of PMCF studies; design and implementation of PMCF studies; and the use of information from PMCF studies.
The TGA (together with all other working group members) invite interested parties to comment on the document: Proposed update to document on Post-Market Clinical Follow-Up Studies
Further information about IMDRF consultations
Further details about current (and closed) consultations, including how to make submissions, are available on the Consultations page of the IMDRF website.